Nucleocytoplasmic shuttling is a specific property also of estrogen receptor β (ERβ) [14, 15], a member of the nuclear receptor superfamily of transcriptional regulators [16] that shows oncosuppressive activities in BC and other cancers. The gene discussed is ESR2; the disease is cancer.